RGC100

RGC100 is an immune stimulant drug. It has a molecular weight of 64.9 KDa that activated dendritic cells of the human immune system. It specifically targets endosomal TLR3 with good solubility and serum stability.^[1]

References

^ Naumann, Kai; Wehner, Rebekka; Schwarze, Anett; Petzold, Christiane; Schmitz, Marc; Rohayem, Jacques (2013). "Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100". Clinical and Developmental Immunology. 2013: 283649. doi:10.1155/2013/283649. PMC 3878805. PMID 24454470.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

[1] Naumann, Kai; Wehner, Rebekka; Schwarze, Anett; Petzold, Christiane; Schmitz, Marc; Rohayem, Jacques (2013). "Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100". Clinical and Developmental Immunology. 2013: 283649. doi:10.1155/2013/283649. PMC 3878805. PMID 24454470.

[1]